Cargando…

Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China

INTRODUCTION: Genetic variability in genes encoding drug-metabolizing enzymes may contribute to the heterogeneity of drug responses in different populations. Extensive research in pharmacogenomics in major populations around the world provides us with a great deal of information about drug-related g...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Li, Qiuyan, Dong, Bonan, Liang, Xiao, Jia, Mansha, Bai, Jing, Yu, Jingcui, Fu, Songbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643223/
https://www.ncbi.nlm.nih.gov/pubmed/34876832
http://dx.doi.org/10.2147/PGPM.S339854
_version_ 1784609838907523072
author Zhang, Tingting
Li, Qiuyan
Dong, Bonan
Liang, Xiao
Jia, Mansha
Bai, Jing
Yu, Jingcui
Fu, Songbin
author_facet Zhang, Tingting
Li, Qiuyan
Dong, Bonan
Liang, Xiao
Jia, Mansha
Bai, Jing
Yu, Jingcui
Fu, Songbin
author_sort Zhang, Tingting
collection PubMed
description INTRODUCTION: Genetic variability in genes encoding drug-metabolizing enzymes may contribute to the heterogeneity of drug responses in different populations. Extensive research in pharmacogenomics in major populations around the world provides us with a great deal of information about drug-related genetic polymorphisms. OBJECTIVE: The purpose of this study was to detect the genetic variation of drug-metabolism-related genes in the five ethnic minorities Daur, Hezhen, Ewenki, Mongolian and Manchu in China, and to analyze the distribution differences among ethnic groups. METHODS: We genotyped 32 SNPs of drug metabolism genes in 882 healthy Chinese volunteers from five ethnic groups. The genotype frequency and allele frequency of the five ethnic groups were calculated, and the different variants among the five ethnic groups were compared by chi-square test. Genetic parameters were analyzed using Popgene software. The genetic structure of five ethnic minorities was analyzed by principal component analysis, and compared with 26 populations. RESULTS: We found that SNPs of genes related to drug metabolism existed diversity in different populations. Among them, rs8192766 and rs9419082 in CYP2E1 showed statistical differences between Daur and Manchu, and NAT2 rs1801280 showed statistical differences between Hezhen and Mongolian. In addition, the five populations we studied had the smallest differences with EAS populations. There was haplotype diversity in CHST3, VKORC1, CYP1A2 and CYP2E1 genes in the five ethnic minorities, and these haplotype polymorphisms were related to the use of corresponding drug doses. Cluster analysis shows that the five ethnic minorities in Heilongjiang Province are clustered together with the EAS populations. CONCLUSION: These results suggest that understanding the diversity of drug-related genetic markers is critical for individualized drug gene therapy programs in ethnic minorities in China as well as in populations highly mixed with these ethnic groups.
format Online
Article
Text
id pubmed-8643223
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86432232021-12-06 Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China Zhang, Tingting Li, Qiuyan Dong, Bonan Liang, Xiao Jia, Mansha Bai, Jing Yu, Jingcui Fu, Songbin Pharmgenomics Pers Med Original Research INTRODUCTION: Genetic variability in genes encoding drug-metabolizing enzymes may contribute to the heterogeneity of drug responses in different populations. Extensive research in pharmacogenomics in major populations around the world provides us with a great deal of information about drug-related genetic polymorphisms. OBJECTIVE: The purpose of this study was to detect the genetic variation of drug-metabolism-related genes in the five ethnic minorities Daur, Hezhen, Ewenki, Mongolian and Manchu in China, and to analyze the distribution differences among ethnic groups. METHODS: We genotyped 32 SNPs of drug metabolism genes in 882 healthy Chinese volunteers from five ethnic groups. The genotype frequency and allele frequency of the five ethnic groups were calculated, and the different variants among the five ethnic groups were compared by chi-square test. Genetic parameters were analyzed using Popgene software. The genetic structure of five ethnic minorities was analyzed by principal component analysis, and compared with 26 populations. RESULTS: We found that SNPs of genes related to drug metabolism existed diversity in different populations. Among them, rs8192766 and rs9419082 in CYP2E1 showed statistical differences between Daur and Manchu, and NAT2 rs1801280 showed statistical differences between Hezhen and Mongolian. In addition, the five populations we studied had the smallest differences with EAS populations. There was haplotype diversity in CHST3, VKORC1, CYP1A2 and CYP2E1 genes in the five ethnic minorities, and these haplotype polymorphisms were related to the use of corresponding drug doses. Cluster analysis shows that the five ethnic minorities in Heilongjiang Province are clustered together with the EAS populations. CONCLUSION: These results suggest that understanding the diversity of drug-related genetic markers is critical for individualized drug gene therapy programs in ethnic minorities in China as well as in populations highly mixed with these ethnic groups. Dove 2021-11-30 /pmc/articles/PMC8643223/ /pubmed/34876832 http://dx.doi.org/10.2147/PGPM.S339854 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Tingting
Li, Qiuyan
Dong, Bonan
Liang, Xiao
Jia, Mansha
Bai, Jing
Yu, Jingcui
Fu, Songbin
Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
title Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
title_full Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
title_fullStr Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
title_full_unstemmed Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
title_short Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
title_sort genetic polymorphism of drug metabolic gene cyps, vkorc1, nat2, dpyd and chst3 of five ethnic minorities in heilongjiang province, northeast china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643223/
https://www.ncbi.nlm.nih.gov/pubmed/34876832
http://dx.doi.org/10.2147/PGPM.S339854
work_keys_str_mv AT zhangtingting geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT liqiuyan geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT dongbonan geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT liangxiao geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT jiamansha geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT baijing geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT yujingcui geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina
AT fusongbin geneticpolymorphismofdrugmetabolicgenecypsvkorc1nat2dpydandchst3offiveethnicminoritiesinheilongjiangprovincenortheastchina